Joe C Mathew And Vandana Gombar

Chinese drugs pose threat to Indian pharma

Cheap bulk drug imports from China may soon post a threat to the Rs 20,000 crore (Rs 200 billion) domestic bulk drug industry.

WHO's new pact to boost Indian pharma

The proposal will help India, one of the most cost-effective location for pharmaceutical production, to increase its growing generic exports multifold in a hassle-free regulatory environment.

Fortis eyes Trehan's Medicity

Fortis Healthcare Limited is close to picking up a majority stake in Naresh Trehan's upcoming Medicity project in Gurgaon, with the contours of the agreement expected to be finalised within a month.

Lab norms to hit small drug firms

Small scale drug makers fear that they may have to shell out anything between Rs 20 lakh (Rs 2 million) to Rs 1 crore (Rs 10 million) for acquiring land and equipment as mandated by the new GLP.

Special abatement rate for drug prices on anvil

The central government is likely to prescribe a special rate of abatement on the retail prices of drugs for calculation of excise duty.

IOC - Reliance of the public sector?

The company, ranked 153rd on the Fortune list, is appointing a consultant to explore the possibilities, as part of an internal due-diligence followed for any new business.

Say yes to honey, dump sugar

Why US oil giants kept away from auction

Indian cyberspace under attack

Indian call centres under threat

FD with a company, a good biz option

How he started 10 firms in 10 years

Outsourcing: A shot in the arm for IT

India's power woes may finally be over

Is the Delhi Metro a costly mistake?